Company profile: Molecular Medicine
1.1 - Company Overview
Company description
- Provider of process R&D, process and assay development, clinical manufacturing, fill/finish, and GMP storage services.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Molecular Medicine
CHEORS
HQ: United States
Website
- Description: Provider of health economics and outcomes research services, including development, review, and quality assurance of health economic models, early decision models, country adaptations for HTA submissions, systematic literature reviews, meta-analyses, and database analyses, plus market-access planning and tailored payer tools to support reimbursement and access decisions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CHEORS company profile →
3P Biopharmaceuticals
HQ: Spain
Website
- Description: Provider of biologics and cell therapy development and manufacturing services. Offers comprehensive CDMO support, including process and analytical development, preclinical and clinical supply, and commercial production. Produces proteins via mammalian (CHO, NS0, BHK-21, HEK293, Hybridoma) and microbial (E. coli, P. pastoris, S. cerevisiae, H. pylori, S. noursei) systems, and provides cell therapy technology transfer, process development, cell culture, and GMP certification.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full 3P Biopharmaceuticals company profile →
Argot Partners
HQ: United States
Website
- Description: Provider of corporate and financial communications consultancy services to public and private companies, investment funds, and high net worth individuals, leveraging broad agency and industry experience to address challenges facing growing companies and those in distress.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Argot Partners company profile →
Build Clinical
HQ: United States
Website
- Description: Provider of a HIPAA-compliant platform and services to accelerate clinical research patient recruitment, including custom digital ads on search engines, health websites, and social media; study-specific landing pages; pre-screen questionnaires; real-time participant data management; monthly analytics reporting; and 24/7 support.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Build Clinical company profile →
Arranta Bio
HQ: United States
Website
- Description: Provider of contract development and manufacturing services, including GMP RNA solutions (plasmid, RNA, lipid nanoparticle production), biologics development and cGMP manufacturing, viral vector and live virus manufacturing, GMP cell and virus banking, and microbiome services developing and manufacturing live biotherapeutic products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Arranta Bio company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Molecular Medicine
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Molecular Medicine
2.2 - Growth funds investing in similar companies to Molecular Medicine
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Molecular Medicine
4.2 - Public trading comparable groups for Molecular Medicine
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →